Autres langues Organogenesis Holdings Inc.

Actions

ORGO

US68621F1021

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/05/2024			Varia. 5j.	Varia. 1 janv.
2,63 ^USD	-2,23 %		-4,01 %	-35,70 %

13/05	ORGANOGENESIS HOLDINGS INC. : Morgan Stanley maintient sa recommandation neutre	ZM
09/05	Transcript : Organogenesis Holdings Inc., Q1 2024 Earnings Call, May 09, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN	14/05
Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	10/05
Organogenesis: Q1 Earnings Snapshot	09/05
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M	09/05
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results	09/05
Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024	09/05
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis	02/05
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	02/05
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	16/04
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	03/04
Organogenesis: Q4 Earnings Snapshot	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M	29/02
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	29/02
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	12/02
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	08/02
Organogenesis Holdings Insider Sold Shares Worth $940,860, According to a Recent SEC Filing	11/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Organogenesis Holdings Inc.

Actions

ORGO

US68621F1021

Autres langues

Filtres